These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2623222)

  • 21. Medical treatment of peptic ulcer disease.
    Andersen BN
    Acta Chir Scand Suppl; 1988; 547():88-92. PubMed ID: 2906493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omeprazole for peptic ulcer in Crohn's disease.
    Bianchi Poro G; Ardizzone S; Petrillo M; Desideri S
    Am J Gastroenterol; 1991 Feb; 86(2):245-6. PubMed ID: 1992643
    [No Abstract]   [Full Text] [Related]  

  • 23. Omeprazole, amoxicillin and bismuth for peptic ulcer healing and Helicobacter pylori eradication.
    Treiber G; Walker S; Klotz U
    Arzneimittelforschung; 1997 Jan; 47(1):47-50. PubMed ID: 9037444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of omeprazole therapy on peptic disease and serum gastrin levels in hemodialysis patients. A preliminary study.
    Montemurro NE; Di Maggio A; Loperfido A; Franceschi M; Scatizzi A
    Clin Nephrol; 1993 Nov; 40(5):296-8. PubMed ID: 8281719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Which patients with ulcer- or reflux-like dyspepsia will respond favorably to omeprazole?
    Singh A; Newton W
    J Fam Pract; 2001 Apr; 50(4):365. PubMed ID: 11300989
    [No Abstract]   [Full Text] [Related]  

  • 26. [What is the current therapeutic role of omeprazole in gastroduodenal ulcer disease?].
    Gisbert JP; Boixeda D; Martín de Argila C
    Rev Esp Enferm Dig; 1997 Feb; 89(2):116-23. PubMed ID: 9115818
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term follow-up after eradication of Helicobacter pylori with omeprazole, clarithromycin, and tinidazole (OCT regimen) in a Japanese population.
    Ando T; Minami M; Mizuno T; Watanabe O; Ishiguro K; Ina K; Kusugami K; Nobata K; Nishiwaki T; Tsuzuki T; Shimada M; El-Omar E; Goto H
    Helicobacter; 2005 Oct; 10(5):379-84. PubMed ID: 16181347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Peptic ulcer: changing indications for gastric resection during the last 15 years].
    Della Beffa V; Carelli-Basile A; Leli R; Fontana D
    Minerva Chir; 1994 Nov; 49(11):1065-9. PubMed ID: 7708225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Helicobacter pylori eradication on the healing and recurrence of peptic ulcer: combination therapy with low-dose omeprazole and clarithromycin.
    Uemura N; Okamoto S; Mukai T; Yamaguchi S; Kaji M; Hrruma K; Sumii K; Kajiyama G
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S67-9. PubMed ID: 8574740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of 1-week and 2-week triple therapy with omeprazole, amoxicillin, and clarithromycin in peptic ulcer patients with Helicobacter pylori infection: results of a randomized controlled trial.
    Kiyota K; Habu Y; Sugano Y; Inokuchi H; Mizuno S; Kimoto K; Kawai K
    J Gastroenterol; 1999; 34 Suppl 11():76-9. PubMed ID: 10616771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advances in the knowledge of peptic-acid dependent diseases].
    Mazure PA; Pigliacampo J
    Acta Gastroenterol Latinoam; 1989; 19(3):165-73. PubMed ID: 2576850
    [No Abstract]   [Full Text] [Related]  

  • 32. [Peptic ulcer disease etiology, diagnosis and treatment].
    Bak-Romaniszyn L; Wojtuń S; Gil J; Płaneta-Małecka I
    Pol Merkur Lekarski; 2004; 17 Suppl 1():128-32. PubMed ID: 15603370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lansoprazole: a comprehensive review.
    Zimmermann AE; Katona BG
    Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Bullous pemphigoid secondary corticoresistant. Inhibitory role of omeprazole on corticosteroid metabolism?].
    Chosidow O; Joly P; Laurent-Puig P; Prost C; Espagne E; Wechsler J; Roujeau JC; Revuz J
    Ann Dermatol Venereol; 1991; 118(1):45-6. PubMed ID: 2018306
    [No Abstract]   [Full Text] [Related]  

  • 35. [New developments in ulcer therapy: famotidine, omeprazole misoprostol].
    Gugler R
    Med Klin (Munich); 1986 Mar; 81(6):208-13. PubMed ID: 3097476
    [No Abstract]   [Full Text] [Related]  

  • 36. Cell kinetics of the gastric mucosa of patients treated with omeprazole.
    Biasco G; Mordenti P; Brandi G; Paganelli GM; Santucci R; Miglioli M
    Am J Gastroenterol; 1996 Mar; 91(3):621-2. PubMed ID: 8633536
    [No Abstract]   [Full Text] [Related]  

  • 37. [Therapy of peptic ulcer. ATPase inhibitors].
    Arnold R
    Verh Dtsch Ges Inn Med; 1988; 94():276-81. PubMed ID: 2974671
    [No Abstract]   [Full Text] [Related]  

  • 38. [Omeprazole. An effective antisecretory agent in ulcerative disease and reflux esophagitis].
    Lauritsen K; Laursen LS; Madsen JR
    Ugeskr Laeger; 1989 Jul; 151(28):1831-3. PubMed ID: 2773093
    [No Abstract]   [Full Text] [Related]  

  • 39. [Reduced ex vivo production of superoxide anion by polymorphonuclear leukocytes during therapy with omeprazole. A pharmacological effect?].
    Capodicasa E; Ciaccio V; Corazzi F; De Bellis F; Bucaneve G; Ficola F; Pelli MA
    Minerva Gastroenterol Dietol; 1994 Sep; 40(3):105-11. PubMed ID: 7948319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Misoprostol vs omeprazole for ulcers associated with NSAIDs.
    Bell AD
    Can Fam Physician; 1998 Nov; 44():2371-2. PubMed ID: 9839045
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.